Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Evidence that the prevalence of childhood overweight is plateauing: data from nine countries.

Olds T, Maher C, Zumin S, Péneau S, Lioret S, Castetbon K, Bellisle, de Wilde J, Hohepa M, Maddison R, Lissner L, Sjöberg A, Zimmermann M, Aeberli I, Ogden C, Flegal K, Summerbell C.

Int J Pediatr Obes. 2011 Oct;6(5-6):342-60. doi: 10.3109/17477166.2011.605895. Epub 2011 Aug 12. Review.

PMID:
21838570
2.

Can we improve the diagnosis of renal failure? A revised coding system for the Middle East and North Africa.

Neild GH, Oygar DD, Hmida MB.

Saudi J Kidney Dis Transpl. 2011 Jul;22(4):651-61. Review.

3.

The identification of CFHR5 nephropathy.

Gale DP.

J R Soc Med. 2011 May;104(5):186-90. doi: 10.1258/jrsm.2011.11k013. No abstract available.

4.

Trends in renal replacement therapy in Turkey, 1996-2008.

Süleymanlar G, Serdengeçti K, Altiparmak MR, Jager K, Seyahi N, Erek E; Turkish Registry of Nephrology, Dialysis, and Transplantation.

Am J Kidney Dis. 2011 Mar;57(3):456-65. doi: 10.1053/j.ajkd.2010.12.007.

PMID:
21335249
5.

Global variation in renal replacement therapy for end-stage renal disease.

Caskey FJ, Kramer A, Elliott RF, Stel VS, Covic A, Cusumano A, Geue C, Macleod AM, Zwinderman AH, Stengel B, Jager KJ.

Nephrol Dial Transplant. 2011 Aug;26(8):2604-10. doi: 10.1093/ndt/gfq781. Epub 2011 Jan 18.

PMID:
21245131
6.

A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study.

Süleymanlar G, Utaş C, Arinsoy T, Ateş K, Altun B, Altiparmak MR, Ecder T, Yilmaz ME, Çamsari T, Başçi A, Odabas AR, Serdengeçti K.

Nephrol Dial Transplant. 2011 Jun;26(6):1862-71. doi: 10.1093/ndt/gfq656. Epub 2010 Nov 4.

8.

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.

Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC.

Lancet. 2010 Sep 4;376(9743):794-801. doi: 10.1016/S0140-6736(10)60670-8. Epub 2010 Aug 25.

9.

UK Renal Registry 12th Annual Report (December 2009): chapter 3: UK ESRD incident rates in 2008: national and centre-specific analyses.

Byrne C, Ford D, Gilg J, Ansell D, Feehally J.

Nephron Clin Pract. 2010;115 Suppl 1:c9-39. doi: 10.1159/000299800. Epub 2010 Mar 31.

10.

UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons.

Boddana P, Caskey F, Casula A, Ansell D.

Nephron Clin Pract. 2009;111 Suppl 1:c269-76. doi: 10.1159/000210003. Epub 2009 Mar 26.

11.

Initiation of dialysis at higher GFRs: is the apparent rising tide of early dialysis harmful or helpful?

Rosansky SJ, Clark WF, Eggers P, Glassock RJ.

Kidney Int. 2009 Aug;76(3):257-61. doi: 10.1038/ki.2009.161. Epub 2009 May 20. Review.

12.

What do we know about chronic renal failure in young adults? I. Primary renal disease.

Neild GH.

Pediatr Nephrol. 2009 Oct;24(10):1913-9. doi: 10.1007/s00467-008-1108-3. Epub 2009 Feb 4. Review. Erratum in: Pediatr Nephrol. 2009 Oct;24(10):2079-80.

PMID:
19190936
13.

Genes mirror geography within Europe.

Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, Auton A, Indap A, King KS, Bergmann S, Nelson MR, Stephens M, Bustamante CD.

Nature. 2008 Nov 6;456(7218):98-101. doi: 10.1038/nature07331. Epub 2008 Aug 31. Erratum in: Nature. 2008 Nov 13;456(7219):274.

14.

Prevalence of overweight and obesity among 11-year-old children in Cyprus, 1997-2003.

Savva SC, Tornaritis MJ, Chadjigeorgiou C, Kourides YA, Siamounki M, Kafatos A.

Int J Pediatr Obes. 2008;3(3):186-92. doi: 10.1080/17477160701705451.

PMID:
18612872
15.

How can we achieve global equity in provision of renal replacement therapy?

White SL, Chadban SJ, Jan S, Chapman JR, Cass A.

Bull World Health Organ. 2008 Mar;86(3):229-37.

16.

Diabetes and chronic kidney disease: lessons from the Pima Indians.

Lemley KV.

Pediatr Nephrol. 2008 Nov;23(11):1933-40. doi: 10.1007/s00467-008-0763-8. Epub 2008 Mar 5. Review.

PMID:
18320236
17.

Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans.

Agodoa L, Eggers P.

Semin Dial. 2007 Nov-Dec;20(6):577-85. Review.

PMID:
17991208
18.

COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy.

Voskarides K, Damianou L, Neocleous V, Zouvani I, Christodoulidou S, Hadjiconstantinou V, Ioannou K, Athanasiou Y, Patsias C, Alexopoulos E, Pierides A, Kyriacou K, Deltas C.

J Am Soc Nephrol. 2007 Nov;18(11):3004-16. Epub 2007 Oct 17.

19.

Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.

Stewart JH, McCredie MR, Williams SM, Jager KJ, Trpeski L, McDonald SP; ESRD Incidence Study Group.

Nephrology (Carlton). 2007 Oct;12(5):520-7.

PMID:
17803478
20.

Mitochondrial control region sequences from northern Greece and Greek Cypriots.

Irwin J, Saunier J, Strouss K, Paintner C, Diegoli T, Sturk K, Kovatsi L, Brandstätter A, Cariolou MA, Parson W, Parsons TJ.

Int J Legal Med. 2008 Jan;122(1):87-9. Epub 2007 May 11.

PMID:
17492459

Supplemental Content

Support Center